Emerging 2026 Research Is Pointing to a New Root Cause of High Blood Pressure — and What Can Finally Be Done About It
I've been treating men on lisinopril, amlodipine and metoprolol for twenty years. For most of those twenty years, the field didn't have a clear answer for why their dose only ever went up.
That's changed.
Over the last several years, a body of research has been building across cardiology, hypertension, and blood-flow journals — and in 2026, what was once a fringe hypothesis is becoming the broadly accepted explanation: blood pressure that keeps climbing on your pills is, at its core, a condition of thick blood.
You don't need to take my word for it. Open a new tab and type "blood viscosity and high blood pressure" into Google. Look at what comes up.
Medical journals. Research universities. Clinical reviews. This isn't fringe. It's where the science has landed.
Here's what that actually means.
What Fibrinogen Is
Right inside your blood, there's a sticky clotting protein floating in every drop called fibrinogen. Think of it as cornstarch stirred into gravy, but alive, and carried through every artery, every vein, and every tiny capillary in your body, ready to plug every leak.
When you're young and fibrinogen is low, your blood is thin and slippery. It glides through your vessels without drag. You don't feel it. It does its job invisibly.
But your blood needs specific clot-clearing enzymes to stay that way — the cleanup crew it uses to break fibrinogen back down, keep the plasma thin, and keep the red cells from stacking.
As you age, that cleanup slows down. Your body produces less of what breaks fibrinogen down. Stress, salt, extra pounds, and accumulated wear speed the process up. Your blood stops getting thinned out.
So it thickens up.
Fibrinogen-heavy blood loses its thin, slippery quality. It thickens. It stacks. And as it stacks, it begins to physically drag against every vessel it runs through — including the millions of tiny ones that set the number on your cuff.
And once you understand that mechanism, every symptom you've been carrying makes sense.
The cuff stuck at 142
Thick blood drags through every vessel from head to toe. When it crawls through that many miles of pipe at once, your cuff reads 141 at breakfast and 147 after work on the same 20 mg of lisinopril — because the entire system is under pressure.
The 10 mg that became 40
Your pill loosens the pipe your blood runs through. When the blood inside stays thick, the number creeps back and 10 mg becomes 20, then 40, then a second pill.
Grabbing the dresser when you stand
When the blood stays too thick to push the number down, the pills widen every pipe in your body instead. The room goes grey when you stand because the pressure that should reach your head drains into pipes opened wide.
Asleep in the recliner by 8
When your blood runs thick, every heartbeat costs more than it should. By 8 at night, you're asleep in the recliner not because you're getting old — but because your heart spent all day pushing syrup against resistance from the inside.
The Research Behind It
This isn't a single study or a fringe theory. It's a converging body of work across multiple labs and journals:
People with high blood pressure had thicker blood than people without it — and fibrinogen was largely why their plasma ran thick.
Untreated high blood pressure came with thicker blood and more resistance in the vessels — and the two rose together.
In North American adults with high blood pressure, nattokinase lowered diastolic pressure in 8 weeks while placebo didn't move it — most in men.
Across six randomized trials, nattokinase cut systolic pressure 3.45 points versus placebo — as an add-on for high blood pressure.
These are a few papers out of dozens. All peer-reviewed, all in PubMed, all published in major medical journals.
The 2023 meta-analysis is the most recent — and it confirms, in six randomized trials, that nattokinase brings the cuff number down on top of what you already take.
The findings are public. They've just been slow to reach clinical practice.
Why Nothing You've Tried Has Worked
Lisinopril, amlodipine, metoprolol, water pills — every prescription you've been given for high blood pressure is designed to do the same thing: work the pipe, the tank, or the pump — never the blood.
None of them touch the reason your pressure is high in the first place. The thick blood is still there, still dragging through every vessel it fills, still pushing up the number your pills are trying to hold down.
That's why the dose only ever goes up. Nothing in your medicine cabinet was ever pointed at your blood.
What Thinning Thick Blood Actually Requires
It's the same mechanism, in reverse.
Your blood thickened because your body stopped making enough of what breaks fibrinogen down. Give that back, and the fibrinogen breaks down. As it breaks down, the blood thins. As it thins, it releases its drag on every vessel it's been crawling through — and the stubborn readings, the creeping dose, and the talk of a second pill start to resolve at the source.
There's no shortcut around this. You can't widen the pipe far enough, or cut the salt low enough, to fix a problem that lives inside the blood. The blood has to be thinned from the inside, with the enzyme it lost.
I spent years recommending the closest things I could find — garlic pills, beet powder, hibiscus tea. I kept coming back to the same conclusion: the ingredients existed, but nothing was putting them together correctly.
So in early 2025, I decided to build the formulation myself.
I teamed up with a small group of hypertension and blood-flow researchers, and we spent the better part of a year working through the literature, sourcing the right forms of each ingredient, and testing the formulation. By the end of 2025, we had it.
Noverly Nattokinase
The formulation centers on three core actives — chosen because they're each in the form that actually reaches the blood.
They're supported by CoQ10, bromelain, turmeric, aged garlic, pine bark, and dandelion root — a matrix that helps the actives absorb and reach the blood.
Every ingredient is research-backed. Every dose is based on what the peer-reviewed literature supports. Nothing is in there for marketing — no proprietary blend, no 2,000 FU half-dose, no ingredients that look impressive on a label but don't reach the blood.
What Happened With The First 1,000 Customers
In early 2026 we ran an initial launch and tracked outcomes from our first 1,000 customers across the first 90 days on the protocol. Among those who completed the full 90 days:
These aren't clinical trial numbers. They're self-reported outcomes from real customers — most of whom had been on blood pressure pills for over five years and had already tried garlic, beets, and hibiscus.
Most reported the shift starting between week three and week six. By day 90, the majority were describing it the same way: not a number held down by one more pill, but a number good enough that their doctor brought up the dose.
If you've been on blood pressure pills long enough to know that loosening the pipe isn't the same as thinning the blood, Noverly is built for what you've actually been looking for.
Try it for 90 days.
If it doesn't work for you in that window, send it back. Full refund. No questions, no fine print, no return process designed to wear you down. I don't want patients paying for something that isn't helping them.